Labshake search
Citations for R&D Systems :
401 - 450 of 3933 citations for 4 Methoxy 2 2 3 4 5 5 Hexacb 13C12 99% 50 Ug Ml In Toluene since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Molecular Biology 2022Quote: ... the transfected cells were treated with 5 ng/ml TGF-β1 (R&D Systems) for 24 hours ...
-
bioRxiv - Cancer Biology 2023Quote: ... and 5 ng/ml RANKL (R&D Systems Catalog #462-TEC-010; Lot # CWA2622011), which is the previously reported EC50 needed for primary bone marrow cell differentiation into osteoclasts ...
-
bioRxiv - Immunology 2023Quote: ... BMDMs were treated with recombinant mouse SPARCL1 (5-20 μg/ml, R&D system, #4547-SL ...
-
bioRxiv - Cancer Biology 2023Quote: ... Cells were permeabilized and stained with 5 μg/ml anti-BrdU (R&D Systems). Samples were imaged with a glycerol-immersion ACS_APO 20x/NA 0.60 objective (Leica ...
-
bioRxiv - Cell Biology 2024Quote: ... containing 5 µg/ml rDLK1 resuspended in PBS (R&D Systems, #1144-PR-025) or PBS vehicle ...
-
bioRxiv - Immunology 2020Quote: ... recombinant IL-4 (R&D systems), and anti-CD40 (ThermoFisher ...
-
bioRxiv - Cancer Biology 2024Quote: ... Anti-4-HNE (R&D Systems) was used with an AF647 secondary antibody (Invitrogen ...
-
bioRxiv - Cell Biology 2022Quote: ... Type 2 (BME-2) droplets (R&D Systems, Minneapolis, MN, USA) and covered under medium ...
-
bioRxiv - Immunology 2022Quote: ... and MΦs with IL-4 (20ng/ml) and IL-13 (20ng/ml; denoted ‘IL4/13’ for brevity; R&D Systems) in MΦ media ...
-
bioRxiv - Immunology 2022Quote: ... in the presence of IL-2 (10 ng ml−1, R&D Systems), anti-IL-10 (50 μg ml−1 ...
-
bioRxiv - Microbiology 2021Quote: ... supplemented with 20 IU/mL rhIL-2 (R&D Systems Cat# 202-IL) for 72±4 hours at 37°C and 5% CO2 ...
-
bioRxiv - Microbiology 2020Quote: ... and 2 ng/ml recombinant mouse TGF-β (R&D Systems, Minneapolis, MN).
-
bioRxiv - Immunology 2020Quote: ... anti-human IL-37 (2 μg/ml, goat polyclonal, R&D Systems, AF1975), anti-human caspase-1 p20 (1:1000 ...
-
bioRxiv - Neuroscience 2023Quote: ... supplemented with 20 ng/mL FGF-2 (R&D Systems, 233-FB-010), and 20 ng/mL PDGF-AA (R&D Systems ...
-
bioRxiv - Cancer Biology 2022Quote: ... and recombinant human IL-2 20 ng/ml (202-IL, R&D Systems). The QCM Leukocyte Migration Assay (MilliporeSigma ...
-
bioRxiv - Bioengineering 2024Quote: ... and 10 ng/ml fibroblast growth factor-2 (R&D Systems, Minneapolis, MN). For pellet cultures ...
-
bioRxiv - Developmental Biology 2020Quote: ... pH 7.4 and then incubated overnight at 4°C with mouse monoclonal anti-CD154 (1:50, R&D systems, MAB617) and rabbit anti-calbindinD28k (1:500 ...
-
bioRxiv - Bioengineering 2023Quote: ... the samples were incubated overnight at 4°C with the primary antibodies for A2B5 (1:50; R&D Systems, MAB1416) and NG2 (1:300 ...
-
bioRxiv - Cancer Biology 2023Quote: 10^4 LECs were seeded on 96-well plates pre-coated with 50 μl of Cultrex (3433, R&D Systems) and incubated 24 h in the cell incubator ...
-
bioRxiv - Immunology 2020Quote: ... and 1 μg/ml CD40-ligand-HA with 5 ng/ml anti-HA antibodies (R&D Systems, Minneapolis, USA), and separately in combination with IL-4 and IL-21 (100 IU each) ...
-
bioRxiv - Bioengineering 2022Quote: MONHA-encapsulated hydrogels were cultured in MONHA growth medium for 21 days followed by treatment with increasing doses of TGFβ2 (vehicle control, 2.5 ng/ml, 5 ng/ml, and 10 ng/ml; R&D Systems, Minneapolis, MN) for 7 days ...
-
bioRxiv - Immunology 2021Quote: ... Blocking of ACE2 was performed with 8 ug/mL anti-ACE2 (R&D systems) for 30 min at 37°C before adding stimuli ...
-
bioRxiv - Bioengineering 2022Quote: ... were coated with 4 μg ml-1 recombinant mouse IL-10 receptor alpha (R&D Systems) overnight at 4°C ...
-
bioRxiv - Molecular Biology 2022Quote: ... M2 macrophages were generated by stimulating Mϕ with 20 ng/ml IL-4 (R&D Systems) and 20 ng/ml IL-13 (R&D system ...
-
bioRxiv - Immunology 2021Quote: ... 115-006-068), 250ng/ml mouse recombinant MEGACD40L (Enzo, ALX-522-120) and 20ng/ml Recombinant mouse IL-4 (R&D system, 404-ML). Cells were collected at specific time points for analysis ...
-
bioRxiv - Immunology 2022Quote: ... Primary B cell complete media also contains 5 ng/ml of BAFF (R&D Systems).
-
bioRxiv - Molecular Biology 2020Quote: Mice fibroblast cells (FLS) treated with 5 ng/mL recombinant human TNF (R&D Systems) for 16 hours were harvested at 95% confluence ...
-
bioRxiv - Neuroscience 2022Quote: ... the media was supplemented with 40 ng/ml 3,3’,5-triiodothronine (T3, R&D systems). The spheroids were maintained in spheroid media from day 70 until completion of the experiment with half-media changes every other day ...
-
bioRxiv - Cell Biology 2021Quote: ... Medium was changed to differentiation medium supplemented with 5 ng/ml VEGF (R&D Systems) and 5 µmol/L XAV (Stemgent) ...
-
bioRxiv - Cell Biology 2021Quote: ... medium was changed to differentiation medium supplemented with 5 ng/ml VEGF (R&D Systems). After Day 8 ...
-
bioRxiv - Developmental Biology 2021Quote: ... Media was changed to differentiation media supplemented with 5 ng/ml VEGF (R&D Systems) and 5 µmol/L XAV (Stemgent) ...
-
bioRxiv - Developmental Biology 2021Quote: ... media was changed to differentiation media supplemented with 5 ng/ml VEGF (R&D Systems). After day 8 ...
-
bioRxiv - Immunology 2022Quote: ... neutralising anti-IFNγ or isotype control (mouse IgG2b, both 5 μg/mL, R&D Systems) were added to cultures ...
-
bioRxiv - Cancer Biology 2022Quote: ... Cells were treated with 5 ng/mL recombinant human TGFβ1 (R&D Systems, 240-B) prepared according to the manufacture’s specifications ...
-
bioRxiv - Microbiology 2023Quote: ... Hyphae were incubated with soluble CD56 (5 µg/mL, R&D Systems, Minneapolis, MN, USA) or BSA (control ...
-
bioRxiv - Immunology 2023Quote: ... 5 µg/ml of recombinant mouse Siglec-E-Fc chimera (R&D Systems, Cat. 5806) in 100 μl of buffer (10mM Tris-HCl (pH7.4) ...
-
bioRxiv - Immunology 2019Quote: ... and macrophage inflammatory protein-2 (MIP-2) (R&D Systems, Minneapolis, MN) according to the manufacturer’s instructions ...
-
bioRxiv - Plant Biology 2019Quote: ... DuoSet IC ELISA kit (DYC1767-2 and DYC1766-2, R&D Systems) according to the manufacturer’s instructions ...
-
Nanoparticle-delivered TLR4 and RIG-I agonists enhance immune response to SARS-CoV-2 subunit vaccinebioRxiv - Immunology 2022Quote: ... plates were incubated for 2 h at RT with 500 ng/mL (25 ng/well) recombinant biotinylated human ACE-2 (R&D Systems, Cat# BT933-020) diluted in PBSTBA ...
-
bioRxiv - Immunology 2023Quote: ... Cells were cultured for 4 days in the presence of 20ng/ml murine recombinant IL-12 (R&D systems; 419-ML). The proportion of IFNγ-secreting CD4+ T-cells (Th1 cells ...
-
bioRxiv - Cancer Biology 2021Quote: ... active caspase-3 (R&D Systems AF835; 1:50), and Vimentin (CST 5741 ...
-
bioRxiv - Cell Biology 2023Quote: ... anti-Galectin-3 (1:50; R&D systems, AF1197), anti-Hsp70 (1:300 ...
-
bioRxiv - Genetics 2021Quote: ... 3 ng/ml mouse IL-3 (R&D Systems) and 20% L-cell conditioned medium ...
-
bioRxiv - Developmental Biology 2022Quote: ... PBS was removed and 50 μl of cell lysis buffer (Cell Lysis Buffer 2, R&D Systems, # 895347) were added ...
-
bioRxiv - Immunology 2022Quote: ... and 1 μg/ml CD40-ligand-HA with 5 ng/ml anti-HA antibodies (both R&D Systems, Minneapolis, USA), and Type B CpG OND D-SL01 (InvivoGen ...
-
bioRxiv - Bioengineering 2019Quote: ... 0.25 ng/mL BMP4 (PeptroTech 315-27) and 5 ng/mL Activin A (R&D Systems 338-AC-050/CF) were added to the SF differentiation medium ...
-
bioRxiv - Cell Biology 2020Quote: ... during 2 hours and stimulated with human recombinant VEGF165 (25ng/ml, R&D System) during 30 minutes.
-
bioRxiv - Immunology 2019Quote: ... NK cells were activated for 72h in 300IU/ml rhIL-2 (R&D Systems). CD4 T cells were simultaneously activated and infected as described above ...
-
bioRxiv - Cell Biology 2021Quote: ... 0.1% 2-Mercaptoethanol and 10 ng/mL basic FGF (R&D Systems, 233-FB). For MyoD+F/R/C condition ...
-
bioRxiv - Systems Biology 2020Quote: ... or mouse anti-TNFα Receptors 1 and 2 (10 µg/mL, R&D Systems) (see Figure 1-Figure Supplement 4B ...